Johnson & Johnson

Eli Lilly

Bristol-Myers

Viatris

Catalent

Zoetis

Royalty Pharma

Pfizer

Merck

Intra-Cellular Therapies

iShares U.S. Pharmaceuticals ETF

IHE tracks a broad-based, cap-weighted index of US pharmaceutical companies.

iShares U.S. Healthcare Providers ETF

Health Care Select Sector SPDR Fund

Healthcare stocks and sector-related exchange traded funds found support from a strong start to the earnings season after UnitedHealth Group (NYSE: UNH) and Johnson & Johnson (NYSE: JNJ) provided a much needed boost to a lagging market segment.

Johnson & Johnson, UnitedHealth Give Healthcare ETFs a Much Needed Bolster Shot

First Trust Nasdaq Pharmaceuticals ETF 

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

SPDR S&P Pharmaceuticals ETF

Despite robust results, pharma ETFs have been trending downward in a month.

Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

iShares Evolved U.S. Innovative Healthcare ETF

iShares U.S. Healthcare ETF

Vanguard Health Care ETF

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Despite such robust results, pharma ETFs have been trending downward in a month.

Pharma ETFs Down Despite Solid Q1 Results

Recent comments by UnitedHealthcare highlighted the risk of health care reform.

Health Care Funds To Avoid

News for iShares U.S. Pharmaceuticals ETF ETF (IHE)